CN107233566B - 猪瘟-猪圆环二联亚单位的疫苗及其制备方法和应用 - Google Patents
猪瘟-猪圆环二联亚单位的疫苗及其制备方法和应用 Download PDFInfo
- Publication number
- CN107233566B CN107233566B CN201710023628.7A CN201710023628A CN107233566B CN 107233566 B CN107233566 B CN 107233566B CN 201710023628 A CN201710023628 A CN 201710023628A CN 107233566 B CN107233566 B CN 107233566B
- Authority
- CN
- China
- Prior art keywords
- protein
- vaccine
- swine fever
- porcine circovirus
- circovirus type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000282898 Sus scrofa Species 0.000 title claims abstract description 51
- 206010037660 Pyrexia Diseases 0.000 title claims abstract description 30
- 229940031626 subunit vaccine Drugs 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 241001533384 Circovirus Species 0.000 title claims abstract description 13
- 229960005486 vaccine Drugs 0.000 claims abstract description 82
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 51
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 51
- 241001673669 Porcine circovirus 2 Species 0.000 claims abstract description 44
- 239000002671 adjuvant Substances 0.000 claims abstract description 26
- 101900173079 Classical swine fever virus Envelope glycoprotein E2 Proteins 0.000 claims abstract description 19
- 108091007433 antigens Proteins 0.000 claims abstract description 16
- 102000036639 antigens Human genes 0.000 claims abstract description 16
- 239000000427 antigen Substances 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 101710125507 Integrase/recombinase Proteins 0.000 claims description 16
- 208000015181 infectious disease Diseases 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical group [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 3
- 229940033663 thimerosal Drugs 0.000 claims description 3
- 101100382437 Porcine circovirus 2 Cap gene Proteins 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 claims 5
- 239000007853 buffer solution Substances 0.000 claims 2
- 230000003053 immunization Effects 0.000 abstract description 30
- 238000002649 immunization Methods 0.000 abstract description 30
- 241000710777 Classical swine fever virus Species 0.000 abstract description 25
- 241000700605 Viruses Species 0.000 abstract description 11
- 241001465754 Metazoa Species 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 230000005847 immunogenicity Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 208000001726 Classical Swine Fever Diseases 0.000 description 9
- 206010008631 Cholera Diseases 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 241000202347 Porcine circovirus Species 0.000 description 4
- 241000282887 Suidae Species 0.000 description 4
- 229960005030 other vaccine in atc Drugs 0.000 description 4
- 101710172711 Structural protein Proteins 0.000 description 3
- 229940031416 bivalent vaccine Drugs 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 2
- 108010076039 Polyproteins Proteins 0.000 description 2
- 102000002067 Protein Subunits Human genes 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940031551 inactivated vaccine Drugs 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 208000028489 postweaning multisystemic wasting syndrome Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002845 virion Anatomy 0.000 description 2
- 101150044789 Cap gene Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101710118188 DNA-binding protein HU-alpha Proteins 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- 102100038353 Gremlin-2 Human genes 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 101001032860 Mus musculus Gremlin-2 Proteins 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000005119 Necrotizing Pneumonia Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 101710144128 Non-structural protein 2 Proteins 0.000 description 1
- 101710144111 Non-structural protein 3 Proteins 0.000 description 1
- 101800001020 Non-structural protein 4A Proteins 0.000 description 1
- 101800001019 Non-structural protein 4B Proteins 0.000 description 1
- 101800001014 Non-structural protein 5A Proteins 0.000 description 1
- 101710199667 Nuclear export protein Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000710778 Pestivirus Species 0.000 description 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000012865 aseptic processing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940030156 cell vaccine Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710023628.7A CN107233566B (zh) | 2017-01-13 | 2017-01-13 | 猪瘟-猪圆环二联亚单位的疫苗及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710023628.7A CN107233566B (zh) | 2017-01-13 | 2017-01-13 | 猪瘟-猪圆环二联亚单位的疫苗及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107233566A CN107233566A (zh) | 2017-10-10 |
CN107233566B true CN107233566B (zh) | 2022-05-27 |
Family
ID=59982974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710023628.7A Active CN107233566B (zh) | 2017-01-13 | 2017-01-13 | 猪瘟-猪圆环二联亚单位的疫苗及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107233566B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109125719B (zh) * | 2017-06-19 | 2022-06-14 | 普莱柯生物工程股份有限公司 | 一种含猪圆环病毒3型、猪圆环病毒2型抗原的免疫原性组合物及其应用 |
CN109091669A (zh) * | 2018-09-19 | 2018-12-28 | 天康生物股份有限公司 | 猪瘟-圆环混合抗原的制备方法及其产品、猪瘟-圆环二联亚单位疫苗及其制备方法 |
CN110038124B (zh) * | 2019-05-13 | 2023-04-14 | 天康生物股份有限公司 | 猪瘟-猪传染性胸膜肺炎二联亚单位的疫苗及其制备方法和应用 |
CN112494643B (zh) * | 2020-12-09 | 2022-07-12 | 西安电子科技大学 | 一种猪csfv-pcv二联dna疫苗及其制备方法 |
CN113058032B (zh) * | 2021-03-22 | 2022-07-12 | 武汉科前生物股份有限公司 | 一种猪瘟、猪伪狂犬病和猪圆环病毒2型三联亚单位疫苗及其制备方法和应用 |
CN114230677B (zh) * | 2022-02-23 | 2022-05-10 | 北京中海生物科技有限公司 | 含有猪瘟E2和圆环病毒的Cap的重组蛋白及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160068575A1 (en) * | 2014-09-05 | 2016-03-10 | Chung Yuan Christian University | Novel recombinant baculovirus vector and uses thereof |
WO2017200484A1 (en) * | 2016-05-19 | 2017-11-23 | Temasek Life Sciences Laboratory Limited | Multivalent vaccines against major swine viral diseases |
-
2017
- 2017-01-13 CN CN201710023628.7A patent/CN107233566B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160068575A1 (en) * | 2014-09-05 | 2016-03-10 | Chung Yuan Christian University | Novel recombinant baculovirus vector and uses thereof |
WO2017200484A1 (en) * | 2016-05-19 | 2017-11-23 | Temasek Life Sciences Laboratory Limited | Multivalent vaccines against major swine viral diseases |
Non-Patent Citations (1)
Title |
---|
猪圆环病毒 2 型 ORF2 基因与猪瘟病毒 E2 基因在奶山羊胎儿成纤维细胞中的表达与生物活性的鉴定,高珊,《爱学术》数据库猪圆环病毒 2 型 ORF2 基因与猪瘟病毒 E2 基因在奶山羊胎儿成纤维细胞中的表达与生物活性的鉴定;高珊;《爱学术》;20160528;摘要、引文、结论 * |
Also Published As
Publication number | Publication date |
---|---|
CN107233566A (zh) | 2017-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107233566B (zh) | 猪瘟-猪圆环二联亚单位的疫苗及其制备方法和应用 | |
JP7088835B2 (ja) | ブタサーコウイルス3型免疫原性組成物、その製造方法、およびその使用方法 | |
JP5200223B2 (ja) | Pcv2抗原によるブタの処置 | |
Rodriguez et al. | Development of vaccines toward the global control and eradication of foot-and-mouth disease | |
US20200237894A1 (en) | Pcv2 orf2 carrier platform | |
Robinson et al. | Global Foot‐and‐Mouth Disease Research Update and Gap Analysis: 3‐Vaccines | |
EP3035958B1 (en) | Porcine circovirus type 2 (pcv2) subunit vaccine | |
Lyons et al. | Challenges of generating and maintaining protective vaccine-induced immune responses for foot-and-mouth disease virus in pigs | |
JP2011511754A (ja) | 不顕性pcvdの予防及び治療 | |
US20140348874A1 (en) | Method for the reduction of pcv-2 in a herd of swine | |
CN111658768A (zh) | 一种非洲猪瘟的多组分亚单位疫苗及其制备方法和应用 | |
US11896659B2 (en) | Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof | |
CN109535233A (zh) | 猪瘟病毒嵌合型病毒样颗粒、制备方法及其应用和疫苗 | |
CN103908664A (zh) | 一种疫苗组合物及其制备方法 | |
US9975923B2 (en) | Methods and compositions for norovirus blockade epitopes | |
CN113940992B (zh) | 一种非洲猪瘟亚单位疫苗组合物及其制备方法和应用 | |
CN102727883B (zh) | 猪繁殖与呼吸综合征与猪瘟二联疫苗及其用途 | |
CN104288760A (zh) | 一种疫苗组合物及其制备方法和应用 | |
CN111840533B (zh) | A型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用 | |
RU2801949C1 (ru) | Штамм "СК" вируса классической чумы свиней Pestivirus для изготовления биопрепаратов для специфической профилактики классической чумы свиней | |
CN104248758A (zh) | 一种疫苗组合物及其制备方法和应用 | |
CN116120468B (zh) | 一种预防禽呼肠孤病毒的病毒样颗粒疫苗及其制备方法 | |
CN107970443A (zh) | 牛病毒性腹泻病毒e2蛋白亚单位疫苗组合物及其制备方法和应用 | |
Xie et al. | Dynamics of serological and mucosal antibody responses against african swine fever viruses in experimentally infected pigs | |
RU2774926C2 (ru) | Вакцина, включающая белок orf2 pcv2 генотипа 2b |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 312366 No. 1, Baichuan Road, Binhai New Area, Shaoxing City, Zhejiang Province Applicant after: NOVO BIOTECH Corp. Address before: 312000 5th floor, building 2, science and innovation center, 398 mahuan Road, Binhai New Town, Shaoxing City, Zhejiang Province Applicant before: NOVO BIOTECH Corp. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 312366 No. 1, Baichuan Road, Binhai New Area, Shaoxing City, Zhejiang Province Patentee after: Zhejiang Hailong Biotechnology Co.,Ltd. Country or region after: China Address before: 312366 No. 1, Baichuan Road, Binhai New Area, Shaoxing City, Zhejiang Province Patentee before: NOVO BIOTECH Corp. Country or region before: China |